Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy.
暂无分享,去创建一个
L. Magee | P. von Dadelszen | M. Helewa | E. Rey | Laura A Magee | Michael Helewa | Evelyne Rey | A. Pels
[1] A. Caughey,et al. The use of ultrasound to detect small-for-gestational-age infants in patients with elevated human chorionic gonadotropin on maternal serum screening. , 2010, American journal of perinatology.
[2] S. Zubrick,et al. Hypertensive diseases of pregnancy and the development of behavioral problems in childhood and adolescence: the Western Australian Pregnancy Cohort Study. , 2009, The Journal of pediatrics.
[3] Y. Poel,et al. Psychological treatment of women with psychological complaints after pre-eclampsia , 2009, Journal of psychosomatic obstetrics and gynaecology.
[4] Gary L Darmstadt,et al. Reducing stillbirths: screening and monitoring during pregnancy and labour , 2009, BMC pregnancy and childbirth.
[5] R. Newman,et al. A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy. , 1999, American journal of obstetrics and gynecology.
[6] G Koren,et al. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis , 2000, The Lancet.
[7] D. Towner,et al. Obstetric outcomes in women with elevated maternal serum human chorionic gonadotropin. , 2006, American journal of obstetrics and gynecology.
[8] D. Henderson-smart,et al. A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: the PIVOT trial. , 2007, The Australian & New Zealand journal of obstetrics & gynaecology.
[9] J. Canick,et al. Second-Trimester Levels of Maternal Serum Human Chorionic Gonadotropin and Inhibin A as Predictors of Preeclampsia in the Third Trimester of Pregnancy , 2000, The Journal of the Society for Gynecologic Investigation: JSGI.
[10] J. Troendle,et al. Risks of hypertensive disorders in the second pregnancy. , 2001, Paediatric and perinatal epidemiology.
[11] J. Lumley,et al. Interventions for promoting smoking cessation during pregnancy. , 2004, The Cochrane database of systematic reviews.
[12] R. Hermida,et al. Administration Time–Dependent Influence of Aspirin on Blood Pressure in Pregnant Women , 2003, Hypertension.
[13] Kypros H Nicolaides,et al. An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. , 2005, American journal of obstetrics and gynecology.
[14] S. Millard,et al. Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension. , 1999, Obstetrics and gynecology.
[15] Jan Pryor,et al. Perinatal predictors of neurodevelopmental outcome in small-for-gestational-age children at 18 months of age. , 2002, American journal of obstetrics and gynecology.
[16] K. Leveno,et al. Severe preeclampsia and the very low birth weight infant: is induction of labor harmful? , 1999, Obstetrics and gynecology.
[17] D. Taylor,et al. Hypertension in Pregnancy: Which Method of Blood Pressure Measurement is Most Predictive of Outcome? , 1996, Obstetrics and gynecology.
[18] R. Bortolus,et al. Nifedipine administered in pregnancy: effect on the development of children at 18 months , 2000, BJOG : an international journal of obstetrics and gynaecology.
[19] S. Twaddle,et al. Screening and surveillance of pregnancy hypertension--an economic approach to the use of daycare. , 1990, Bailliere's clinical obstetrics and gynaecology.
[20] L. Butters,et al. First year of life after the use of atenolol in pregnancy associated hypertension. , 1984, Archives of disease in childhood.
[21] P. Rebulla. Platelet transfusion trigger in difficult patients. , 2001, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.
[22] C. Callander,et al. Coagulation screening before epidural analgesia in pre‐eclampsia , 1991, Anaesthesia.
[23] S. Kaur,et al. Biophysical profile in the treatment of intrauterine growth-restricted fetuses who weigh <1000 g. , 2008, American journal of obstetrics and gynecology.
[24] N. Marlow,et al. Protocol for the Smoking, Nicotine and Pregnancy (SNAP) trial: double-blind, placebo-randomised, controlled trial of nicotine replacement therapy in pregnancy , 2007, BMC Health Services Research.
[25] U. Hanson,et al. Epidemiology of pregnancy‐induced hypertension and preeclampsia in Type 1 (insulin‐dependent) diabetic pregnancies in Sweden , 1998, Acta obstetricia et gynecologica Scandinavica.
[26] S. Heinonen,et al. OBSTETRIC PROGNOSIS IN SECOND PREGNANCY AFTER PREECLAMPSIA IN FIRST PREGNANCY , 2000, Hypertension in pregnancy.
[27] Risk Factors for Preeclampsia, Abruptio Placentae, and Adverse Neonatal Outcomes among Women with Chronic Hypertension , 1998 .
[28] R. Resnik,et al. Evaluation of the use of continuous lumbar epidural anesthesia for hypertensive pregnant women in labor. , 1985, American journal of obstetrics and gynecology.
[29] B. Sibai,et al. Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications. , 2007, American journal of obstetrics and gynecology.
[30] Trial of calcium to prevent preeclampsia. , 1997, The New England journal of medicine.
[31] J. Pell,et al. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129 290 births , 2001, The Lancet.
[32] F. Althabe,et al. Ambulatory versus conventional methods for monitoring blood pressure during pregnancy. , 2002, The Cochrane database of systematic reviews.
[33] R. Kakuma,et al. Energy and protein intake in pregnancy. , 2003, The Cochrane database of systematic reviews.
[34] G. Espinosa,et al. Catastrophic antiphospholipid syndrome: updated diagnostic algorithms. , 2010, Autoimmunity reviews.
[35] I. Russell,et al. Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: pragmatic randomised trial , 2005, BMJ : British Medical Journal.
[36] D. Chou,et al. Magnesium sulphate versus diazepam for eclampsia. , 2010, The Cochrane database of systematic reviews.
[37] B. Sibai,et al. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. , 1994, American journal of obstetrics and gynecology.
[38] B. Young,et al. Effects of Magnesium Sulfate on Toxemic Patients in Labor , 1977, Obstetrics and gynecology.
[39] G. Bonsel,et al. One‐year infant outcome in women with early‐onset hypertensive disorders of pregnancy , 2007, BJOG : an international journal of obstetrics and gynaecology.
[40] R. Greene,et al. Does increased resistance on umbilical artery Doppler preclude a trial of labour? , 1998, European journal of obstetrics, gynecology, and reproductive biology.
[41] K. Leveno,et al. Outpatient management of mild pregnancy induced hypertension , 1995 .
[42] S. Yeo. A randomized comparative trial of the efficacy and safety of exercise during pregnancy: design and methods. , 2006, Contemporary clinical trials.
[43] P. Gartside,et al. Prenatal Screening for Anticardiolipin Antibody , 1990, American journal of perinatology.
[44] B. Sibai,et al. Eclampsia. VII. Pregnancy outcome after eclampsia and long-term prognosis. , 1992, American journal of obstetrics and gynecology.
[45] W. Fetter,et al. A randomised controlled trial comparing two temporising management strategies, one with and one without plasma volume expansion, for severe and early onset pre‐eclampsia , 2005, BJOG : an international journal of obstetrics and gynaecology.
[46] M. Lindheimer,et al. Explaining and predicting preeclampsia. , 2006, The New England journal of medicine.
[47] T. Dowswell,et al. Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy. , 2010, The Cochrane database of systematic reviews.
[48] M. Torloni,et al. Does sodium nitroprusside kill babies? A systematic review. , 2007, Sao Paulo medical journal = Revista paulista de medicina.
[49] Mervi Jokinen,et al. The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community , 2005, BMJ : British Medical Journal.
[50] P. Morgan. The Effect of Increasing Central Blood Volume to Decrease the Incidence of Hypotension Following Spinal Anesthesia for Cesarean Section , 2007 .
[51] S. Matsubara,et al. Recurrence Risk of Preterm Birth due to Preeclampsia , 2002, Gynecologic and Obstetric Investigation.
[52] A. Ulloa-Aguirre,et al. Protein:creatinine ratio in random urine samples is a reliable marker of increased 24-hour protein excretion in hospitalized women with hypertensive disorders of pregnancy. , 2007, Clinical chemistry.
[53] S. Campbell,et al. The role of color Doppler imaging of the uterine arteries at 20 weeks' gestation in stratifying antenatal care , 1998, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[54] K. Palmer,et al. Risk of prematurity, low birthweight and pre-eclampsia in relation to working hours and physical activities: a systematic review , 2006, Occupational and Environmental Medicine.
[55] Lawrence A Leiter,et al. The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy. , 2006, The Canadian journal of cardiology.
[56] J. Pell,et al. Pregnancy complications and subsequent maternal cerebrovascular events: a retrospective cohort study of 119,668 births. , 2004, American journal of epidemiology.
[57] F. Audibert,et al. Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women. , 2010, American journal of obstetrics and gynecology.
[58] D. Chestnut,et al. A Randomized Trial of Intrapartum Analgesia in Women With Severe Preeclampsia , 2002, Obstetrics and gynecology.
[59] M. Kilby,et al. Optimal bedside urinalysis for the detection of proteinuria in hypertensive pregnancy: a study of diagnostic accuracy , 2005, BJOG : an international journal of obstetrics and gynaecology.
[60] B. Mercer,et al. A prospective comparison of total protein/creatinine ratio versus 24-hour urine protein in women with suspected preeclampsia. , 2003, American journal of obstetrics and gynecology.
[61] D. Mathews,et al. A randomized controlled trial of complete bed rest versus ambulation in the management of proteinuric hypertension during pregnancy , 1982, British journal of obstetrics and gynaecology.
[62] A. Logan,et al. A Survey of Canadian Practitioners Regarding the Management of the Hypertensive Disorders of Pregnancy , 2004, Hypertension in pregnancy.
[63] D. Rocke,et al. Rapidly progressive laryngeal oedema associated with pregnancy‐aggravated hypertension , 1992, Anaesthesia.
[64] A. Makris,et al. Postpartum hypertension and nonsteroidal analgesia. , 2004, American journal of obstetrics and gynecology.
[65] R. A. Young,et al. Use of the protein/creatinine ratio of a single voided urine specimen in the evaluation of suspected pregnancy-induced hypertension. , 1996, The Journal of family practice.
[66] D. Turnbull,et al. Antenatal day care units versus hospital admission for women with complicated pregnancy. , 2001, The Cochrane database of systematic reviews.
[67] B Waeber,et al. European Society of Hypertension Practice Guidelines for home blood pressure monitoring , 2010, Journal of Human Hypertension.
[68] K. Harrington,et al. Second-trimester maternal serum inhibin A concentration as an early marker for preeclampsia. , 1999, American journal of obstetrics and gynecology.
[69] C. Redman,et al. FINAL REPORT OF STUDY ON HYPERTENSION DURING PREGNANCY: THE EFFECTS OF SPECIFIC TREATMENT ON THE GROWTH AND DEVELOPMENT OF THE CHILDREN , 1982, The Lancet.
[70] B. Duncan,et al. Aerobic Exercise and Submaximal Functional Capacity in Overweight Pregnant Women: A Randomized Trial , 2005, Obstetrics and gynecology.
[71] R. Lilford,et al. Randomised controlled trial of day care for hypertension in pregnancy , 1992, The Lancet.
[72] B. Carvalho,et al. Neuraxial anesthesia in obstetric patients receiving anticoagulant and antithrombotic drugs. , 2010, International journal of obstetric anesthesia.
[73] A. Baschat. Pathophysiology of Fetal Growth Restriction: Implications for Diagnosis and Surveillance , 2004, Obstetrical & gynecological survey.
[74] M. Merialdi,et al. Methodological and technical issues related to the diagnosis, screening, prevention, and treatment of pre‐eclampsia and eclampsia , 2004, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[75] J. Ray,et al. MOS HIP: McMaster outcome study of hypertension in pregnancy. , 2001, Early human development.
[76] W. Mroczek,et al. Effect of magnesium sulfate on cardiovascular hemodynamics. , 1978, Angiology.
[77] A. van Wassenaer,et al. No association between maternal psychological symptoms and infant outcome after pregnancy complicated by early‐onset hypertensive disorders , 2009, Acta paediatrica.
[78] P. Vigil-De Gracia,et al. Anesthesia in pregnant women with HELLP syndrome , 2001, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[79] A. Hollmen,et al. Lumbar Epidural Analgesia to Improve Intervillous Blood Flow During Labor in Severe Preeclampsia , 1982, Obstetrics and gynecology.
[80] Daniel W. Jones,et al. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. , 2005, Hypertension.
[81] D. Li,et al. Changing paternity and the risk of preeclampsia/eclampsia in the subsequent pregnancy. , 2000, American journal of epidemiology.
[82] R. Olszanecki,et al. Effects of prolonged oral supplementation with l‐arginine on blood pressure and nitric oxide synthesis in preeclampsia , 2005, European journal of clinical investigation.
[83] B. Sibai,et al. Monitored outpatient management of mild gestational hypertension remote from term. , 1994, American journal of obstetrics and gynecology.
[84] S. Rabkin,et al. Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[85] R. Hamlin. The prevention of eclampsia and pre-eclampsia. , 1952, Lancet.
[86] L. Poston,et al. A longitudinal study of biochemical variables in women at risk of preeclampsia. , 2002, American journal of obstetrics and gynecology.
[87] P. Magnus,et al. Changing paternity and time since last pregnancy; the impact on pre-eclampsia risk. A study of 547 238 women with and without previous pre-eclampsia. , 2001, International journal of epidemiology.
[88] T. McElrath,et al. The use of central neuraxial techniques in parturients with factor V leiden mutation. , 2005, Anesthesia and analgesia.
[89] F. Viteri,et al. Effects of routine oral iron supplementation with or without folic acid for women during pregnancy. , 2006, The Cochrane database of systematic reviews.
[90] N. Mosaffa,et al. Random urine protein to creatinine ratio as a diagnostic method of significant proteinuria in pre‐eclampsia , 2006, The Australian & New Zealand journal of obstetrics & gynaecology.
[91] P. Chamberlain,et al. Ultrasound evaluation of amniotic fluid volume. I. The relationship of marginal and decreased amniotic fluid volumes to perinatal outcome. , 1984, American journal of obstetrics and gynecology.
[92] K. Law,et al. Is in-patient management of diastolic blood pressure between 90 and 100 mm Hg during pregnancy necessary? , 1998, Hong Kong medical journal = Xianggang yi xue za zhi.
[93] S. Gange,et al. Physical and psychosocial side effects of antepartum hospital bed rest. , 1993, Nursing research.
[94] C. Rhodes,et al. Diuretics for preventing pre-eclampsia. , 2007, The Cochrane database of systematic reviews.
[95] B. Sibai,et al. Mild gestational hypertension remote from term: progression and outcome. , 2001, American journal of obstetrics and gynecology.
[96] A. Shennan,et al. An accurate automated blood pressure device for use in pregnancy and pre‐eclampsia: the Microlife 3BTO‐A , 2005, BJOG : an international journal of obstetrics and gynaecology.
[97] K. Mahomed. Zinc supplementation in pregnancy. , 1997, The Cochrane database of systematic reviews.
[98] G. Lip,et al. Obstetric and neonatal outcome following chronic hypertension in pregnancy among different ethnic groups. , 1998, QJM : monthly journal of the Association of Physicians.
[99] Caroline A Crowther,et al. Spontaneous preterm delivery in primiparous women at low risk in Denmark: population based study , 2006, BMJ : British Medical Journal.
[100] Á. Atallah,et al. Dietary calcium supplementation for prevention of pre‐eclampsia and related problems: a systematic review and commentary , 2007, BJOG : an international journal of obstetrics and gynaecology.
[101] Trina Stryker,et al. Accuracy of home blood pressure readings: monitors and operators , 2004, Blood pressure monitoring.
[102] A. Gul,et al. Maternal and Fetal Outcomes in HELLP Syndrome Complicated with Acute Renal Failure , 2004, Renal failure.
[103] I. Greer,et al. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. , 2005, Blood.
[104] B. Sibai,et al. Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. , 2007, American journal of obstetrics and gynecology.
[105] L. Duley,et al. Magnesium sulphate versus lytic cocktail for eclampsia. , 2001, The Cochrane database of systematic reviews.
[106] J. Brimacombe. Acute Pharyngolaryngeal Oedema and Pre-Eclamptic Toxaemia , 1992, Anaesthesia and intensive care.
[107] E. Burgess,et al. Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[108] F. Gelal,et al. Cranial MR imaging with clinical correlation in preeclampsia and eclampsia. , 2005, Diagnostic and interventional radiology.
[109] A. Shennan,et al. Inpatient Monitoring on an Outpatient Basis: Managing Hypertensive Pregnancies in the Community Using Automated Technologies , 2001, The Journal of the Society for Gynecologic Investigation: JSGI.
[110] L. Horwood,et al. Comparison of methods to identify significant proteinuria in pregnancy in the outpatient setting , 2008, BJOG : an international journal of obstetrics and gynaecology.
[111] B. Sibai,et al. Pitfalls in diagnosis and management of preeclampsia. , 1988, American journal of obstetrics and gynecology.
[112] R. Collins,et al. Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre‐eclampsia and its complications , 1998, British journal of obstetrics and gynaecology.
[113] G. Lip,et al. Effect of atenolol on birth weight. , 1997, The American journal of cardiology.
[114] Michael B Bracken,et al. Work, leisure-time physical activity, and risk of preeclampsia and gestational hypertension. , 2004, American journal of epidemiology.
[115] Geoffrey A Head,et al. Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study , 2010, BMJ : British Medical Journal.
[116] R. Ness,et al. Periconceptional multivitamin use reduces the risk of preeclampsia. , 2006, American journal of epidemiology.
[117] H. Nisell,et al. Urine albumin/creatinine ratio for the assessment of albuminuria in pregnancy hypertension , 2006, Acta obstetricia et gynecologica Scandinavica.
[118] Mark A. Klebanoff,et al. Aspirin Use and Miscarriage Risk , 2006, Epidemiology.
[119] B. Uerpairojkit,et al. Correlation between random urinary protein-to-creatinine ratio and quantitation of 24-hour proteinuria in preeclampsia. , 2003, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[120] A. Ebrashy,et al. Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial. , 2005, Croatian medical journal.
[121] J. Higgins,et al. The detection, investigation and management of hypertension in pregnancy: executive summary , 2000, The Australian & New Zealand journal of obstetrics & gynaecology.
[122] B. Gutsche,et al. Maternal Catecholamines Decrease During Labor After Lumbar Epidural Anesthesia , 1983, American journal of obstetrics and gynecology.
[123] T. Laskowska-Klita,et al. [Effect of vitamin-mineral supplementation on the status of some microelements in pregnant women]. , 2004, Przeglad lekarski.
[124] G. Prescott,et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study , 2003, BMJ : British Medical Journal.
[125] D. Chou,et al. Magnesium sulphate versus phenytoin for eclampsia. , 2010, The Cochrane database of systematic reviews.
[126] D. Damron. Selective magnesium sulfate prophylaxis for the prevention of eclampsia in women with gestational hypertension. , 2007, Obstetrics and gynecology.
[127] C. van Walraven,et al. Risk of subsequent thromboembolism for patients with pre-eclampsia , 2003, BMJ : British Medical Journal.
[128] M. de Swiet,et al. The management of postpartum hypertension , 2002, BJOG : an international journal of obstetrics and gynaecology.
[129] M. Olovsson,et al. Random albumin/creatinine ratio for quantification of proteinuria in manifest pre‐eclampsia , 2006 .
[130] S. Bottoms,et al. Underappreciated risks of the elderly multipara. , 1995, American journal of obstetrics and gynecology.
[131] B. Sibai,et al. The use of labetalol for attenuation of the hypertensive response to endotracheal intubation in preeclampsia. , 1988, American journal of obstetrics and gynecology.
[132] B. Sibai,et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. , 2006, The New England journal of medicine.
[133] Kortaro Tanaka,et al. Recovery of decreased local cerebral blood flow detected by the xenon/CT CBF method in a patient with eclampsia. , 2000, The Keio journal of medicine.
[134] F. Malone,et al. Quad Screen as a Predictor of Adverse Pregnancy Outcome , 2005, Obstetrics and gynecology.
[135] A. Wakeley,et al. Mode of delivery in pregnancies complicated by preeclampsia with very low birth weight infants. , 1995, Journal of perinatology : official journal of the California Perinatal Association.
[136] J. Polak,et al. Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. , 2000, Radiology.
[137] R. Bagga,et al. Pregnancy Complicated by Severe Chronic Hypertension: A 10-Year Analysis from a Developing Country , 2007, Hypertension in pregnancy.
[138] R. Silver,et al. Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome? , 2007, Current rheumatology reports.
[139] M. Leeflang,et al. Are tests for predicting pre‐eclampsia good enough to make screening viable? A review of reviews and critical appraisal , 2009, Acta obstetricia et gynecologica Scandinavica.
[140] B. Sibai,et al. Anesthetic modification of hemodynamic and neuroendocrine stress responses to cesarean delivery in women with severe preeclampsia. , 1991, Anesthesia and analgesia.
[141] LJ Muglia,et al. Association of early‐onset pre‐eclampsia in first pregnancy with normotensive second pregnancy outcomes: a population‐based study , 2010, BJOG : an international journal of obstetrics and gynaecology.
[142] R. Hermida,et al. Circadian Rhythm of Blood Pressure Challenges Office Values as the “Gold Standard” in the Diagnosis of Gestational Hypertension , 2003, Chronobiology international.
[143] S. Batra,et al. Calcium supplementation for the prevention of pre‐eclampsia , 2009, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[144] A. Jacoby,et al. Women's experiences of participating in the Magpie Trial: a postal survey in the United Kingdom. , 2009, Birth.
[145] G. Ryan,et al. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. , 1986, American journal of obstetrics and gynecology.
[146] J. Vermylen,et al. Anticoagulants and Spinal‐Epidural Anesthesia , 1994, Anesthesia and analgesia.
[147] K. Offord,et al. Does Preoperative Antiplatelet Therapy Increase the Risk of Hemorrhagic Complications Associated With Regional Anesthesia? , 1990, Anesthesia and analgesia.
[148] A. Gülmezoglu,et al. Anticonvulsants for women with pre-eclampsia. , 2000, The Cochrane database of systematic reviews.
[149] A. Lalonde,et al. Active management of the third stage of labour: Prevention and treatment of postpartum hemorrhage , 2009, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.
[150] L. Chesley. Eclampsia: the remote prognosis. , 1978, Seminars in perinatology.
[151] R. Ness,et al. Uric Acid Is as Important as Proteinuria in Identifying Fetal Risk in Women With Gestational Hypertension , 2005, Hypertension.
[152] G. Saade,et al. Vitamins C and E to prevent complications of pregnancy-associated hypertension. , 2010, The New England journal of medicine.
[153] Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. , 1999, The New England journal of medicine.
[154] I. Adams-Chapman. Neurodevelopmental outcome of the late preterm infant. , 2006, Clinics in perinatology.
[155] H. Gerstein,et al. Kidney disease after preeclampsia: a systematic review and meta-analysis. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[156] M. Brown,et al. Efficacy and safety of nifedipine tablets for the acute treatment of severe hypertension in pregnancy. , 2002, American journal of obstetrics and gynecology.
[157] T. Cole,et al. Effect of calcium supplementation in pregnancy on maternal bone outcomes in women with a low calcium intake123 , 2010, The American journal of clinical nutrition.
[158] Y. Batra,et al. Nifedipine attenuates the hypertensive response to tracheal intubation in pregnancy-induced hypertension , 1993, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[159] H. Saconato,et al. Oral drugs for hypertensive urgencies: systematic review and meta-analysis. , 2009, Sao Paulo medical journal = Revista paulista de medicina.
[160] D. Grové,et al. Aggressive or Expectant Management for Patients With Severe Preeclampsia Between 28–34 Weeks' Gestation: A Randomized Controlled Trial , 1990, Obstetrics and gynecology.
[161] D. Kallogjeri,et al. Recurrence of Preeclampsia: Effects of Gestational Age at Delivery of the First Pregnancy, Body Mass Index, Paternity, and Interval Between Births , 2009 .
[162] R. Frydman,et al. Prediction of Preeclampsia or Intrauterine Growth Restriction by Second Trimester Serum Screening and Uterine Doppler Velocimetry , 2004, Fetal Diagnosis and Therapy.
[163] L. Magee,et al. The 24-hour urine collection: gold standard or historical practice? , 2008, American journal of obstetrics and gynecology.
[164] A. Franx,et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial , 2009, The Lancet.
[165] A. Skrondal,et al. Recurrence risk of preeclampsia in twin and singleton pregnancies , 2004, American journal of medical genetics. Part A.
[166] G. Dhall,et al. A Safer and More Effective Treatment Regimen for Eclampsia , 1994, The Australian & New Zealand journal of obstetrics & gynaecology.
[167] K. Arheart,et al. Combined Spinal and Epidural Anesthesia With Low Doses of Intrathecal Bupivacaine in Women With Severe Preeclampsia: A Preliminary Report , 2000, Regional Anesthesia & Pain Medicine.
[168] A. Sekizawa,et al. Lower Rate of Preeclampsia After Antioxidant Supplementation in Pregnant Women with Low Antioxidant Status , 2006, Hypertension in pregnancy.
[169] D. Steinberg,et al. The common prothrombotic factors in nulliparous women do not compromise blood flow in the feto-maternal circulation and are not associated with preeclampsia or intrauterine growth restriction. , 2004, American journal of obstetrics and gynecology.
[170] G. Saade,et al. Vitamin C and E Supplementation to Prevent Spontaneous Preterm Birth: A Randomized Controlled Trial , 2010, Obstetrics and Gynecology.
[171] R. North,et al. Evaluation of Ambulatory and Self-Initiated Blood Pressure Monitors by Pregnant and Postpartum Women , 2001, Hypertension in pregnancy.
[172] R. Frydman,et al. Severe preeclampsia is associated with high inhibin A levels and normal leptin levels at 7 to 13 weeks into pregnancy. , 2003, American journal of obstetrics and gynecology.
[173] C. Homer,et al. The natural history of white coat hypertension during pregnancy , 2005, BJOG : an international journal of obstetrics and gynaecology.
[174] K. Hecher,et al. Fetal growth restriction due to placental disease. , 2004, Seminars in perinatology.
[175] F. Pipkin,et al. Predicting high blood pressure in pregnancy: a multivariate approach , 1998, Journal of hypertension.
[176] A. Calle,et al. Coenzyme Q10 supplementation during pregnancy reduces the risk of pre‐eclampsia , 2009, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[177] Z. Bhutta,et al. Pyridoxine (vitamin B6) supplementation in pregnancy. , 2006, The Cochrane database of systematic reviews.
[178] R. Moss‐Morris,et al. Risk factors for small‐for‐gestational‐age infants by customised birthweight centiles: data from an international prospective cohort study , 2010, BJOG : an international journal of obstetrics and gynaecology.
[179] E. Wallace,et al. Effect of antenatal betamethasone administration on placental vascular resistance , 1999, The Lancet.
[180] K A Douglas,et al. Eclampsia in the United Kingdom , 1994, BMJ.
[181] E. Weiss,et al. Condition at birth of infants with previously absent or reverse umbilical artery end-diastolic flow velocities , 2006, Archives of Gynecology and Obstetrics.
[182] M. Bracken. Major Congenital Malformations after First-Trimester Exposure to ACE Inhibitors , 2007 .
[183] A. Dembińska-kieć,et al. Effects of oral L-arginine on the pulsatility indices of umbilical artery and middle cerebral artery in preterm labor. , 2008, European journal of obstetrics, gynecology, and reproductive biology.
[184] M. Lindheimer,et al. World Health Organization Systematic Review of Screening Tests for Preeclampsia , 2004, Obstetrics and gynecology.
[185] S. Karumanchi,et al. CHAPTER 42 – Renal Complications in Normal Pregnancy , 2010 .
[186] L. Magee,et al. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis , 2003, BMJ : British Medical Journal.
[187] T. Weber,et al. Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil , 2007, European Journal of Clinical Nutrition.
[188] J. Moutquin,et al. Low-dose ASA response using the PFA-100 in women with high-risk pregnancy. , 2009, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.
[189] H. Augustin,et al. Prospective Analysis of Placenta Growth Factor (PlGF) Concentrations in the Plasma of Women with Normal Pregnancy and Pregnancies Complicated by Preeclampsia , 2004, Hypertension in pregnancy.
[190] S. Hernández-Díaz,et al. Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study , 2009, BMJ : British Medical Journal.
[191] L. Shulman. Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor , 2008 .
[192] G. Macones,et al. Antiphospholipid Antibodies in Chronic Hypertension: The Value of Screening During Pregnancy , 1998, American journal of perinatology.
[193] F. Abroug,et al. Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol , 2002, Intensive Care Medicine.
[194] G. ter Riet,et al. Accuracy of serum uric acid determination in predicting pre‐eclampsia: A systematic review , 2006, Acta obstetricia et gynecologica Scandinavica.
[195] B. Vásárhelyi,et al. Family history of early-onset cardiovascular disorders is associated with a higher risk of severe preeclampsia. , 2006, European journal of obstetrics, gynecology, and reproductive biology.
[196] E. Crosby,et al. Obstetrical anaesthesia for a parturient with preeclampsia, HELLP syndrome and acute cortical blindness , 1998, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[197] R. Sherwin,et al. Maternal ketosis and its effects on the fetus. , 1983, Clinics in endocrinology and metabolism.
[198] C. Bodian,et al. Practice Patterns of Anesthesiologists Regarding Situations in Obstetric Anesthesia Where Clinical Management Is Controversial , 1996, Anesthesia and analgesia.
[199] P. Chamberlain,et al. Ultrasound evaluation of amniotic fluid volume. II. The relationship of increased amniotic fluid volume to perinatal outcome. , 1984, American journal of obstetrics and gynecology.
[200] J. Singer,et al. The Control of Hypertension In Pregnancy Study pilot trial , 2007, BJOG : an international journal of obstetrics and gynaecology.
[201] Lelia Duley,et al. Cost‐effectiveness of prophylactic magnesium sulphate for 9996 women with pre‐eclampsia from 33 countries: economic evaluation of the Magpie Trial , 2006, BJOG : an international journal of obstetrics and gynaecology.
[202] K. Khan,et al. Accuracy of Urinalysis Dipstick Techniques in Predicting Significant Proteinuria in Pregnancy , 2004, Obstetrics and gynecology.
[203] C. Redman,et al. Maternal hypertension with superimposed pre‐eclampsia: effects on child development at 7½ years , 1983, British journal of obstetrics and gynaecology.
[204] J. Sundsfjord,et al. A study on oedema mechanism in nephrotic syndrome. , 1986, Scandinavian journal of clinical and laboratory investigation.
[205] Aeilko H. Zwinderman,et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis , 2008, Canadian Medical Association Journal.
[206] G. Koren,et al. Neurocognitive Development of Children Following In-Utero Exposure to Labetalol for Maternal Hypertension: A Cohort Study Using a Prospectively Collected Database , 2010, Hypertension in pregnancy.
[207] J. Martin,et al. Stroke and Severe Preeclampsia and Eclampsia: A Paradigm Shift Focusing on Systolic Blood Pressure , 2005, Obstetrics and gynecology.
[208] M. Walker,et al. Heparin for pregnant women with acquired or inherited thrombophilias. , 2003, The Cochrane database of systematic reviews.
[209] T. N. Abdella,et al. Pregnancy Outcome in 211 Patients With Mild Chronic Hypertension , 1983, Obstetrics and Gynecology.
[210] E. Rey,et al. Home Blood Pressure Levels in Pregnant Women with Chronic Hypertension , 2007, Hypertension in pregnancy.
[211] S. Cnattingius,et al. Preterm and term births of small for gestational age infants: a population‐based study of risk factors among nulliparous women , 1998, British journal of obstetrics and gynaecology.
[212] K. Haram,et al. Serum Urate as a Predictor of Fetal Outcome in Severe Pre‐Eclampsia , 1984, Acta obstetricia et gynecologica Scandinavica.
[213] J. Brisson,et al. The effect of leisure time physical activity on the risk of pre-eclampsia and gestational hypertension. , 1989, Journal of epidemiology and community health.
[214] J. Villar,et al. The relationship between calcium intake and edema-, proteinuria-, and hypertension-getosis: an hypothesis. , 1980, The American journal of clinical nutrition.
[215] L. Magee,et al. Oral beta-blockers for mild to moderate hypertension during pregnancy. , 2000, The Cochrane database of systematic reviews.
[216] R. Niederman. Periodontal treatment did not prevent complications of pregnancy , 2010, Evidence-Based Dentistry.
[217] Á. Atallah,et al. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. , 2002, The Cochrane database of systematic reviews.
[218] G. H. Lambert,et al. Transfer of drugs and other chemicals into human milk. , 2001, Pediatrics.
[219] A. Caruso,et al. Proteinuria and outcome of 444 pregnancies complicated by hypertension. , 1990, American journal of obstetrics and gynecology.
[220] D. Subtil,et al. Risk factors for post-partum complications occurring after preeclampsia and HELLP syndrome. A study in 453 consecutive pregnancies. , 2006, European journal of obstetrics, gynecology, and reproductive biology.
[221] A. Hingorani,et al. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis , 2007, BMJ : British Medical Journal.
[222] A. Baschat,et al. Comprehensive assessment of fetal wellbeing: which Doppler tests should be performed? , 2003, Current opinion in obstetrics & gynecology.
[223] B. Branger,et al. L-Arginine treatment for severe vascular fetal intrauterine growth restriction: a randomized double-bind controlled trial. , 2009, Clinical nutrition.
[224] F. Malone,et al. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). , 2004, American journal of obstetrics and gynecology.
[225] J. Roberts,et al. Recent Insights into the pathogenesis of pre-eclampsia. , 2002, Placenta.
[226] P. Devos,et al. Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomized trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. , 2003, American journal of obstetrics and gynecology.
[227] M. Thompson,et al. Recreational Physical Activity During Pregnancy and Risk of Preeclampsia , 2003, Hypertension.
[228] L. Duley,et al. Garlic for preventing pre-eclampsia and its complications. , 2006, The Cochrane database of systematic reviews.
[229] T. Hulsey,et al. Differences in Black and White Infant Birth Weights: The Role of Maternal Demographic Factors and Medical Complications of Pregnancy , 1991, Southern medical journal.
[230] L. Poston,et al. British Hypertension Society guidelines for hypertension management 1999: summary , 1999, BMJ.
[231] J. Barton,et al. Cost-savings analysis of an outpatient management program for women with pregnancy-related hypertensive conditions. , 2006, Disease management : DM.
[232] E. Rey,et al. Blood Pressure Assessments in Different Subtypes of Hypertensive Pregnant Women: Office Versus Home Patient- or Nurse-Measured Blood Pressure , 2009, Hypertension in pregnancy.
[233] E. A. Friedman,et al. Pregnancy, outcome as related to hypertension, edema, and proteinuria. , 1976, Perspectives in nephrology and hypertension.
[234] A. Coomarasamy,et al. Accuracy of serum uric acid in predicting complications of pre‐eclampsia: a systematic review , 2006, BJOG : an international journal of obstetrics and gynaecology.
[235] L. Magee,et al. Maternal Hypertension and Neonatal Outcome Among Small for Gestational Age Infants , 2005, Obstetrics and gynecology.
[236] P. Sandset,et al. Ante‐ and postnatal risk factors of venous thrombosis: a hospital‐based case–control study , 2008, Journal of thrombosis and haemostasis : JTH.
[237] R. D. Manning,et al. Effects of hypoproteinemia on fluid volumes and arterial pressure. , 1983, The American journal of physiology.
[238] K. Christensen,et al. Higher risk of pre-eclampsia after change of partner. An effect of longer interpregnancy intervals? , 2001, Epidemiology.
[239] Jeffrey R. Wilson,et al. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women , 1994, The Lancet.
[240] Carole Rudra,et al. Perceived exertion during prepregnancy physical activity and preeclampsia risk. , 2005, Medicine and science in sports and exercise.
[241] G. Rydén,et al. The Influence of Different Positions and Korotkoff Sounds on the Blood Pressure Measurements in Pregnancy , 1984, Acta obstetricia et gynecologica Scandinavica. Supplement.
[242] I. Tasha,et al. The value of the middle cerebral to umbilical artery Doppler ratio in the prediction of neonatal outcome in patient with preeclampsia and gestational hypertension. , 2010, Journal of prenatal medicine.
[243] L. Magee,et al. The prediction of adverse maternal outcomes in preeclampsia. , 2004, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.
[244] K. Nasu,et al. Low-dose dopamine in treating acute renal failure caused by preeclampsia. , 1996, Gynecologic and obstetric investigation.
[245] B. Sibai,et al. Safety of labor epidural anesthesia for women with severe hypertensive disease. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. , 1999, American journal of obstetrics and gynecology.
[246] J. F. Hernández-Sierra,et al. EFFICACY OF NITROGLYCERINE INFUSION VERSUS SUBLINGUAL NIFEDIPINE IN SEVERE PRE‐ECLAMPSIA: A RANDOMIZED, TRIPLE‐BLIND, CONTROLLED TRIAL , 2008, Clinical and experimental pharmacology & physiology.
[247] L. Poston,et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial , 1999, The Lancet.
[248] A. Bérard,et al. Discontinuation of antihypertensive drug use during the first trimester of pregnancy and the risk of preeclampsia and eclampsia among women with chronic hypertension. , 2009, American journal of obstetrics and gynecology.
[249] Jennifer G. Lyons,et al. Protein:creatinine ratio in uncomplicated twin pregnancy. , 2010, American journal of obstetrics and gynecology.
[250] T. Leet,et al. Preeclampsia in the parous woman: who is at risk? , 2002, American journal of obstetrics and gynecology.
[251] V. Steinthorsdottir,et al. Recurrence of hypertensive disorder in second pregnancy. , 2006, American journal of obstetrics and gynecology.
[252] R. Ruano,et al. Prevention of preeclampsia with low-dose aspirin -- a systematic review and meta-analysis of the main randomized controlled trials. , 2005, Clinics.
[253] J. Kingdom,et al. Second-trimester prediction of severe placental complications in women with combined elevations in alpha-fetoprotein and human chorionic gonadotrophin. , 2006, American journal of obstetrics and gynecology.
[254] M. Prins,et al. Simple Prepregnant Prediction Rule for Recurrent Early-onset Hypertensive Disease in Pregnancy , 2009, Reproductive Sciences.
[255] P. Olofsson,et al. Prospect for vaginal delivery of growth restricted fetuses with abnormal umbilical artery blood flow. , 2004, Acta obstetricia et gynecologica Scandinavica.
[256] M. Buddie,et al. The Importance of Nonproteinuric Hypertension in Pregnancy , 1995 .
[257] A. Nabhan,et al. A randomized trial of tight vs. less tight control of mild essential and gestational hypertension in pregnancy , 2008, Journal of perinatal medicine.
[258] E. Greimel,et al. Quality of life outcomes in pregnancy and postpartum complicated by hypertensive disorders, gestational diabetes, and preterm birth , 2009, Journal of psychosomatic obstetrics and gynaecology.
[259] F. Légaré,et al. Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review. , 2010, Clinical chemistry.
[260] L. Magee,et al. An international trial of antioxidants in the prevention of preeclampsia (INTAPP). , 2010, American journal of obstetrics and gynecology.
[261] G. Stamp,et al. The psychosocial outcomes of antenatal day care for three medical complications of pregnancy: A randomised controlled trial of 395 women , 2006, The Australian & New Zealand journal of obstetrics & gynaecology.
[262] Y. Herabutya,et al. The use of low‐dose aspirin to prevent preeclampsia , 1996, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[263] S. Kılıc,et al. Predictive value of middle cerebral artery to uterine artery pulsatility index ratio in preeclampsia , 2011, Archives of Gynecology and Obstetrics.
[264] R. North,et al. Perinatal morbidity in chronic hypertension , 1996, British journal of obstetrics and gynaecology.
[265] P. Box. Hyperhomocysteinemia, pregnancy complications, and the timing of investigation , 2005 .
[266] F. Wolf,et al. WORKING CONDITIONS AND ADVERSE PREGNANCY OUTCOME: A META‐ANALYSIS , 2000, Obstetrics and gynecology.
[267] G. Bonsel,et al. A randomized trial of plasma volume expansion in hypertensive disorders of pregnancy: influence on the pulsatility indices of the fetal umbilical artery and middle cerebral artery. , 2005, American journal of obstetrics and gynecology.
[268] D. Henderson-smart,et al. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. , 2014, The Cochrane database of systematic reviews.
[269] W. Fraser,et al. Impact of preeclampsia and gestational hypertension on birth weight by gestational age. , 2002, American journal of epidemiology.
[270] G. Lockitch. Handbook of diagnostic biochemistry and hematology in normal pregnancy , 1993 .
[271] H. Odendaal,et al. Do women with pre-eclampsia and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial , 2002 .
[272] D. Savitz,et al. Hypertensive disorders of pregnancy and stillbirth in North Carolina, 1988 to 1991 , 1995, Acta obstetricia et gynecologica Scandinavica.
[273] L. Devoe,et al. The effects of epidural anesthesia on the Doppler velocimetry of umbilical and uterine arteries in normal and hypertensive patients during active term labor , 1991, Obstetrics and gynecology.
[274] G. Saade,et al. L-Arginine Supplementation in Patients with Gestational Hypertension: A Pilot Study , 2007, Hypertension in pregnancy.
[275] W. May,et al. Thrombotic thrombocytopenic purpura in 166 pregnancies: 1955-2006. , 2008, American journal of obstetrics and gynecology.
[276] C. Antonakos,et al. A Comparison of Walking versus Stretching Exercises to Reduce the Incidence of Preeclampsia: A Randomized Clinical Trial , 2008, Hypertension in pregnancy.
[277] R. D. Manning,et al. Effects of hypoproteinemia on renal hemodynamics, arterial pressure, and fluid volume. , 1987, The American journal of physiology.
[278] L. Magee,et al. Prevention and treatment of postpartum hypertension. , 2005, The Cochrane database of systematic reviews.
[279] M. Brown,et al. Does gestational hypertension become pre‐eclampsia? , 1998, British journal of obstetrics and gynaecology.
[280] C. Samama. Should a normal thromboelastogram allow us to perform a neuraxial block? A strong word of warning , 2003, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[281] T. Hulsey,et al. Early-onset severe preeclampsia: induction of labor vs elective cesarean delivery and neonatal outcomes. , 2008, American journal of obstetrics and gynecology.
[282] E. Lieberman,et al. Use of a random urinary protein-to-creatinine ratio for the diagnosis of significant proteinuria during pregnancy. , 2001, American journal of obstetrics and gynecology.
[283] D. Wilkin,et al. Induction of labour at term. Women not for waiting. , 1993, BMJ.
[284] L. Poston,et al. World Health Organisation multicentre randomised trial of supplementation with vitamins C and E among pregnant women at high risk for pre‐eclampsia in populations of low nutritional status from developing countries , 2009, BJOG : an international journal of obstetrics and gynaecology.
[285] M. Bots,et al. Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia. , 2006, American journal of obstetrics and gynecology.
[286] I. Russell,et al. Outcomes of severe pre‐eclampsia/eclampsia in Yorkshire 1999/2003 , 2005, BJOG : an international journal of obstetrics and gynaecology.
[287] Joshua R. Smith,et al. Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[288] L. Magee,et al. Expectant Management of Severe Preeclampsia Remote from Term: A Structured Systematic Review , 2009, Hypertension in pregnancy.
[289] A. Vambergue,et al. Pregnancy induced hypertension in women with gestational carbohydrate intolerance: the diagest study. , 2002, European journal of obstetrics, gynecology, and reproductive biology.
[290] Z Alfirevic,et al. Biophysical profile for fetal assessment in high risk pregnancies. , 2000, The Cochrane database of systematic reviews.
[291] A. Testa,et al. The duration of hypertension in the puerperium of preeclamptic women: relationship with renal impairment and week of delivery. , 1994, American journal of obstetrics and gynecology.
[292] K. Kario,et al. Masked Hypertension: A Review , 2007, Hypertension Research.
[293] Y. Guérin,et al. Urinary protein/creatinine ratio in hypertensive pregnant women. , 1999, Hypertension in pregnancy.
[294] H. Ashurst,et al. Does admission to hospital for bed rest prevent disease progression or improve fetal outcome in pregnancy complicated by non‐proteinuric hypertension? , 1992 .
[295] W. N. Ngan Kee,et al. A Quantitative, Systematic Review of Randomized Controlled Trials of Ephedrine Versus Phenylephrine for the Management of Hypotension During Spinal Anesthesia for Cesarean Delivery , 2002, Anesthesia and analgesia.
[296] J. Goudemand,et al. Are Haemostatic and Fibrinolytic Parameters Predictors of Preeclampsia in Pregnancy-Associated Hypertension? , 1991, Thrombosis and Haemostasis.
[297] J. Golding,et al. A randomised trial of low dose aspirin for primiparae in pregnancy , 1998, British journal of obstetrics and gynaecology.
[298] L. Poston,et al. Adverse Perinatal Outcomes and Risk Factors for Preeclampsia in Women With Chronic Hypertension: A Prospective Study , 2008, Hypertension.
[299] U. Retzke,et al. [Incidence of hypertension in pregnancy in relation to the definition of hypertension]. , 1994, Zentralblatt fur Gynakologie.
[300] K. Savik,et al. Bedrest compliance for women with pregnancy problems. , 1995, Birth.
[301] Prevention and Management of Postpartum Haemorrhage , 2000 .
[302] M. Kramer,et al. Aerobic exercise for women during pregnancy. , 2006, The Cochrane database of systematic reviews.
[303] G. Ferns,et al. Selenium supplementation and the incidence of preeclampsia in pregnant Iranian women: a randomized, double-blind, placebo-controlled pilot trial. , 2010, Taiwanese journal of obstetrics & gynecology.
[304] J. Singer,et al. Women's Views of Their Experiences in the CHIPS (Control of Hypertension in Pregnancy Study) Pilot Trial , 2007, Hypertension in pregnancy.
[305] J. Carcillo,et al. Plasma Therapies in Thrombotic Syndromes , 2005, The International journal of artificial organs.
[306] A. Trumble,et al. Severe Maternal Morbidity Associated with Hypertensive Disorders in Pregnancy in the United States , 2003, Hypertension in pregnancy.
[307] L. Wee,et al. Central nerve block and coagulation: a survey of obstetric anaesthetists. , 2002, International journal of obstetric anesthesia.
[308] C. Redman,et al. Aspirin, extradural anaesthesia and the MRC Collaborative Low-dose Aspirin Study in Pregnancy (CLASP) , 1992, British journal of anaesthesia.
[309] C. Connolly,et al. COMPARISON OF THE EFFICACY OF CONTINUOUS FUROSEMIDE AND LOW-DOSE DOPAMINE INFUSION IN PREECLAMPSIA/ECLAMPSIA-RELATED OLIGURIA IN THE IMMEDIATE POSTPARTUM PERIOD , 2002, Hypertension in pregnancy.
[310] B. Carleton,et al. Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia. , 2005, American journal of obstetrics and gynecology.
[311] K. Nicolaides,et al. Prediction of pre‐eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy‐associated plasma protein‐A, free β‐human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation , 2006, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[312] T. Horlocker. What’s a nice patient like you doing with a complication like this? Diagnosis, prognosis and prevention of spinal hematoma , 2004, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[313] E. Rey,et al. The prognosis of pregnancy in women with chronic hypertension. , 1994, American journal of obstetrics and gynecology.
[314] L. Green,et al. Managing anticoagulated patients during neuraxial anaesthesia , 2010, British journal of haematology.
[315] S. Sidney,et al. A multivariate analysis of risk factors for preeclampsia , 1992, JAMA.
[316] M. Brown,et al. Inadequacy of Dipstick Proteinuria in Hypertensive Pregnancy , 1995, The Australian & New Zealand journal of obstetrics & gynaecology.
[317] G. Cutter,et al. Low‐dose aspirin therapy to prevent preeclampsia , 1994 .
[318] Chan Jun-mi,et al. International Consensus Statement on an Update of the Classification Criteria for Definite Antiphospholipid Syndrome(APS) , 2008 .
[319] T. Einarson,et al. Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis. , 2006, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.
[320] E. Gallery,et al. EXCRETION OF ANTIHYPERTENSIVE MEDICATION INTO HUMAN BREAST MILK: A SYSTEMATIC REVIEW , 2002, Hypertension in pregnancy.
[321] M. Helewa,et al. Community-based home-care program for the management of pre-eclampsia: an alternative. , 1993, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[322] J. Clive,et al. Elevated Second‐Trimester Maternal Serum hCG Alone or in Combination With Elevated Alpha‐Fetoprotein , 1996, Obstetrics and gynecology.
[323] A. Logan,et al. Serious perinatal complications of non-proteinuric hypertension: an international, multicentre, retrospective cohort study. , 2003, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.
[324] Ana Lúcia Letti Müller,et al. Variation in the Urinary Protein/Creatinine Ratio at Four Different Periods of the Day in Hypertensive Pregnant Women , 2005, Hypertension in pregnancy.
[325] J. Barton,et al. Maternal benefit of corticosteroid therapy in patients with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: impact on the rate of regional anesthesia. , 2002, American journal of obstetrics and gynecology.
[326] E. Schiffrin,et al. The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I - blood pressure measurement, diagnosis and assessment of risk. , 2010, The Canadian journal of cardiology.
[327] B. Sibai,et al. Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas. , 2002, American journal of obstetrics and gynecology.
[328] V. Insler,et al. Treatment of hypertension during pregnancy with hydralazine monotherapy or with combined therapy with hydralazine and pindolol. , 1986, European journal of obstetrics, gynecology, and reproductive biology.
[329] C. Crowther,et al. Magnesium supplementation in pregnancy. , 2001, The Cochrane database of systematic reviews.
[330] J. Bonnar,et al. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre‐eclampsia , 1994, British journal of obstetrics and gynaecology.
[331] D. Young,et al. Fetal health surveillance: antepartum and intrapartum consensus guideline. , 2007, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.
[332] L. Duley,et al. Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction. , 2006, The Cochrane database of systematic reviews.
[333] P. Landsbergis,et al. Psychosocial Work Stress and Pregnancy‐Induced Hypertension , 1996, Epidemiology.
[334] L. A. Wolfe,et al. Exercise in pregnancy and the postpartum period. , 2003, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.
[335] R. T. Lie,et al. Fetal and maternal contributions to risk of pre-eclampsia: population based study , 1998, BMJ.
[336] W. Grobman,et al. Serum Levels of Activin A and Inhibin A and the Subsequent Development of Preeclampsia , 2000, Obstetrics and gynecology.
[337] D. Henderson-smart,et al. Altered dietary salt for preventing pre-eclampsia, and its complications. , 2005, The Cochrane database of systematic reviews.
[338] F. Facchinetti,et al. 24-hour ambulatory blood pressure monitoring: a comparison between transdermal glyceryl-trinitrate and oral nifedipine. , 1999, Hypertension in pregnancy.
[339] G. Koren,et al. Activated protein C in normal human pregnancy and pregnancies complicated by severe preeclampsia: A therapeutic opportunity?* , 2002, Critical care medicine.
[340] C. Rout,et al. Effects of alfentanil and fentanyl on induction of anaesthesia in patients with severe pregnancy-induced hypertension. , 1990, British journal of anaesthesia.
[341] M. Dramaix,et al. Effect of uncomplicated chronic hypertension on the risk of small-for-gestational age birth. , 1997, American journal of epidemiology.
[342] E. Abalos,et al. Bed rest with or without hospitalisation for hypertension during pregnancy. , 2005, The Cochrane database of systematic reviews.
[343] J N Martin,et al. The natural history of HELLP syndrome: patterns of disease progression and regression. , 1991, American journal of obstetrics and gynecology.
[344] A. Larsson,et al. Relationship between urinary albumin and albumin/creatinine ratio during normal pregnancy and pre-eclampsia , 2004, Scandinavian journal of clinical and laboratory investigation.
[345] G. Bonsel,et al. Psychosocial impact of early-onset hypertensive disorders and related complications in pregnancy. , 2007, American journal of obstetrics and gynecology.
[346] B. Sibai,et al. Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis. , 1995, American journal of obstetrics and gynecology.
[347] W Greg Miller,et al. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. , 2006, Clinical chemistry.
[348] J. N. Martin,et al. The recurrence risk of the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) in subsequent gestations. , 1994, American journal of obstetrics and gynecology.
[349] K. Joseph,et al. The Effect of Hypertensive Disorders in Pregnancy on Perinatal Outcomes: A Population-Based Cohort Study , 2002 .
[350] W. Rath,et al. Psychosocial distress associated with treatment of hypertensive diseases in pregnancy. , 2008, Psychosomatics.
[351] C. Baykal,et al. Random Urine Protein-Creatinine Ratio to Predict Proteinuria in New-Onset Mild Hypertension in Late Pregnancy , 2004, Obstetrics and gynecology.
[352] A. Hiett,et al. Outcome of infants delivered between 24 and 28 weeks' gestation in women with severe pre-eclampsia , 2001, The Journal of maternal-fetal medicine.
[353] B. Kestenbaum,et al. Cardiovascular and thromboembolic events following hypertensive pregnancy. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[354] S. Montán,et al. Randomised controlled trial of methyldopa and isradipine in preeclampsia – effects on uteroplacental and fetal hemodynamics , 1996, Journal of perinatal medicine.
[355] I. Greer. Epidemiology, risk factors and prophylaxis of venous thrombo-embolism in obstetrics and gynaecology. , 1997, Bailliere's clinical obstetrics and gynaecology.
[356] H. Lagercrantz,et al. Neonatal adaptation in hypertensive pregnancy — A study of labetalol vs hydralazine treatment , 1993, Journal of perinatal medicine.
[357] M. Swiet,et al. Lack of reproducibility in pregnancy of Korotkoff phase IV as measured by mercury sphygmomanometry , 1996, The Lancet.
[358] A. Griffiths,et al. Induction to delivery time interval in patients with and without preeclampsia: a retrospective analysis , 2002, Acta obstetricia et gynecologica Scandinavica.
[359] C. Best,et al. The recurrence risk of severe de novo pre‐eclampsia in singleton pregnancies: a population‐based cohort , 2009, BJOG : an international journal of obstetrics and gynaecology.
[360] B. Sibai,et al. Antioxidant therapy to prevent preeclampsia: a randomized controlled trial. , 2008, Obstetrics and gynecology.
[361] J. Gandon,et al. P-40: Home blood pressure measured telemetrically in hypertensive pregnant women , 2001 .
[362] M. Makary,et al. Impact of bariatric surgery on hypertensive disorders in pregnancy: retrospective analysis of insurance claims data , 2010, BMJ : British Medical Journal.
[363] D. Taylor,et al. Automated, ambulatory, or conventional blood pressure measurement in pregnancy: which is the better predictor of severe hypertension? , 1997, American journal of obstetrics and gynecology.
[364] Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. , 2000, American journal of obstetrics and gynecology.
[365] A. Çeti̇n,et al. The Effect of Glyceryl Trinitrate on Hypertension in Women with Severe Preeclampsia, HELLP Syndrome, and Eclampsia , 2004, Hypertension in pregnancy.
[366] B. Sibai,et al. Prevention of preeclampsia with low‐dose aspirin in healthy, nulliparous pregnant women , 1993, The New England journal of medicine.
[367] H. Odendaal,et al. Nifedipine or prazosin as a second agent to control early severe hypertension in pregnancy: a randomised controlled trial , 2000, BJOG : an international journal of obstetrics and gynaecology.
[368] R. Gaiser,et al. Circulating Angiogenic Factors and the Risk of Preeclampsia , 2005 .
[369] C. Pieper,et al. Job Stress and Preeclampsia , 1996, Epidemiology.
[370] E. Schiffrin,et al. The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk. , 2006, The Canadian journal of cardiology.
[371] A. Franx,et al. An economic analysis of induction of labour and expectant monitoring in women with gestational hypertension or pre‐eclampsia at term (HYPITAT trial) , 2010, BJOG : an international journal of obstetrics and gynaecology.
[372] François Audibert,et al. Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy: A Meta-Analysis , 2010, Obstetrics and gynecology.
[373] W. Gilbert,et al. Pregnancy outcomes in women with chronic hypertension: a population-based study. , 2007, The Journal of reproductive medicine.
[374] J. Dommisse,et al. Intravenous labetalol and intravenous dihydralazine in severe hypertension in pregnancy. , 1982, Clinical and experimental hypertension. Part B, Hypertension in pregnancy.
[375] Xin Xiao,et al. [Effect and mechanism of L-arginine therapy for fetal growth retardation due to pregnancy-induced hypertension]. , 2007, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.
[376] J. Kleijnen,et al. Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis. , 2008, BMC pregnancy and childbirth.
[377] L. Duley,et al. Exercise or other physical activity for preventing pre-eclampsia and its complications. , 2006, The Cochrane database of systematic reviews.
[378] J. López,et al. Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial. , 2006 .
[379] G. Dildy,et al. Very advanced maternal age: pregnancy after age 45. , 1996, American journal of obstetrics and gynecology.
[380] R. Olszanecki,et al. Effects of oral L-arginine on the foetal condition and neonatal outcome in preeclampsia: a preliminary report. , 2006, Basic & clinical pharmacology & toxicology.
[381] A. Seidler,et al. Antiplatelet agents for preventing pre-eclampsia and its complications. , 2007, The Cochrane database of systematic reviews.
[382] M. Brown,et al. Improved methods of assessing proteinuria in hypertensive pregnancy , 1997, British journal of obstetrics and gynaecology.
[383] M. Kilby,et al. Urine Protein Estimation in Hypertensive Pregnancy: Which Thresholds and Laboratory Assay Best Predict Clinical Outcome? , 2005, Hypertension in pregnancy.
[384] David J. Williams. Pregnancy: a stress test for life , 2003, Current opinion in obstetrics & gynecology.
[385] I. Bernstein,et al. Uterine artery Doppler velocimetry in the detection of adverse obstetric outcomes in women with unexplained elevated maternal serum alpha-fetoprotein levels. , 1995, American journal of obstetrics and gynecology.
[386] G. Y. Wong,et al. Preoperative Antiplatelet Therapy Does Not Increase the Risk of Spinal Hematoma Associated with Regional Anesthesia , 1995, Anesthesia and analgesia.
[387] J. Moodley,et al. Intravenous isradipine in the management of severe hypertension in pregnant and nonpregnant patients. A pilot study. , 1994, American journal of hypertension.
[388] M. L. Buddle,et al. Randomised trial of management of hypertensive pregnancies by Korotkoff phase IV or phase V , 1998, The Lancet.
[389] B. Sibai. Imitators of Severe Preeclampsia , 2007, Obstetrics and gynecology.
[390] P. Mannucci,et al. Mild to moderate reduction of a von Willebrand factor cleaving protease (ADAMTS-13) in pregnant women with HELLP microangiopathic syndrome. , 2003, Haematologica.
[391] S. Lev,et al. Effect of Betamethasone Administration on Fetal Heart Rate Tracing: A Blinded Longitudinal Study , 2005, Fetal Diagnosis and Therapy.
[392] S. Leung,et al. A randomised trial of carbetocin versus syntometrine in the management of the third stage of labour , 2006, BJOG : an international journal of obstetrics and gynaecology.
[393] R. Liston,et al. Random Protein‐Creatinine Ratio for the Quantitation of Proteinuria in Pregnancy , 1997, Obstetrics and gynecology.
[394] M. Lamyian,et al. The effect of garlic tablet on plasma lipids and platelet aggregation in nulliparous pregnants at high risk of preeclampsia. , 2001, European journal of obstetrics, gynecology, and reproductive biology.
[395] L. Magee,et al. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: an updated metaregression analysis. , 2002, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.
[396] José Villar,et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. , 2006, American journal of obstetrics and gynecology.
[397] D. Elbourne,et al. The Salford Third Stage Trial. Oxytocin plus ergometrine versus oxytocin alone in the active management of the third stage of labor. , 1993, The Online journal of current clinical trials.
[398] B. Sibai,et al. Pregnancy outcome of intensive therapy in severe hypertension in first trimester , 1986, Obstetrics and gynecology.
[399] G. Novelli,et al. Early and Late Preeclampsia: Two Different Maternal Hemodynamic States in the Latent Phase of the Disease , 2008, Hypertension.
[400] S. Greene,et al. Pre-eclampsia and the later development of type 2 diabetes in mothers and their children: an intergenerational study from the Walker cohort , 2007, Diabetologia.
[401] A. R. Reed,et al. Hemodynamic Changes Associated With Spinal Anesthesia for Cesarean Delivery in Severe Preeclampsia , 2008 .
[402] Kirsten Duckitt,et al. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies , 2005, BMJ : British Medical Journal.
[403] P. Damm,et al. Improved Pregnancy Outcome in Type 1 Diabetic Women With Microalbuminuria or Diabetic Nephropathy , 2009, Diabetes Care.
[404] J. López,et al. Management of Severe Hypertension in the Postpartum Period with Intravenous Hydralazine or Labetalol: A Randomized Clinical Trial , 2007, Hypertension in pregnancy.
[405] J. Pritchard. The use of the magnesium ion in the management of eclamptogenic toxemias. , 1955, Surgery, gynecology & obstetrics.
[406] J. Simpson,et al. Proteinuria in pre‐eclampsia: how much matters? , 2005, BJOG : an international journal of obstetrics and gynaecology.
[407] L. Brancazio,et al. Pharmacokinetics and pharmacodynamics of subcutaneous heparin during the early third trimester of pregnancy. , 1995, American journal of obstetrics and gynecology.
[408] S. Brennecke,et al. The effect of hospitalisation on ambulatory blood pressure in pregnancy , 2002, The Australian & New Zealand journal of obstetrics & gynaecology.
[409] S. Alahuhta,et al. Maternal and uteroplacental haemodynamic state in pre-eclamptic patients during spinal anaesthesia for Caesarean section. , 1996, British journal of anaesthesia.
[410] K. Nicolaides,et al. Pregnancy First-Trimester Prediction of Hypertensive Disorders in Pregnancy , 2009 .
[411] R. Hermida,et al. Prognostic Value of Office and Ambulatory Blood Pressure Measurements in Pregnancy , 2002, Hypertension.
[412] Recurring Complications in Second Pregnancy , 2009, Obstetrics and gynecology.
[413] B. Sibai,et al. Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis. , 1991, American journal of obstetrics and gynecology.
[414] F. Bonilla-musoles,et al. Ultrasound Markers of Fetal Infection Part 1: Viral Infections , 2005, Ultrasound quarterly.
[415] Ji‐Hyung Park,et al. A case of reversible postpartum cytotoxic edema in preeclampsia , 2004, Journal of the Neurological Sciences.
[416] C. Redman,et al. Hypertension during pregnancy, with and without specific hypotensive treatment. II. The growth and development of the infant in the first year of life. , 1977, Early human development.
[417] J. Borensztajn,et al. Prediction of 24-hour protein excretion in pregnancy with a single voided urine protein-to-creatinine ratio. , 2002, American journal of obstetrics and gynecology.
[418] C. Redman,et al. The clinical utility of routine urinalysis in pregnancy , 2003, The Medical journal of Australia.
[419] B. Gonik,et al. Cardiovascular alterations in severe pregnancy-induced hypertension: acute effects of intravenous magnesium sulfate. , 1984, American journal of obstetrics and gynecology.
[420] J. Brichant,et al. Belgian guidelines concerning central neural blockade in patients with drug-induced alteration of coagulation: an update. , 2005, Acta anaesthesiologica Belgica.
[421] D. Churchill,et al. Fetal growth restriction , 2000, The Lancet.
[422] M. Rönnback,et al. Renal and vascular function in women with previous preeclampsia: a comparison of low- and high-degree proteinuria. , 2006, Kidney international.
[423] W. Dunsmuir,et al. Can we predict recurrence of pre‐eclampsia or gestational hypertension? , 2007, BJOG : an international journal of obstetrics and gynaecology.
[424] L. Duley,et al. Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia. , 2010, The Cochrane database of systematic reviews.
[425] L. Geerts,et al. Severe early onset pre-eclampsia: prognostic value of ultrasound and Doppler assessment , 2007, Journal of Perinatology.
[426] W. Leisenring,et al. Dietary fiber, potassium, magnesium and calcium in relation to the risk of preeclampsia. , 2005, The Journal of reproductive medicine.
[427] L. Magee,et al. Do Commonly Used Oral Antihypertensives Alter Fetal or Neonatal Heart Rate Characteristics? A Systematic Review , 2004, Hypertension in pregnancy.
[428] B. Sibai,et al. Acute fatty liver of pregnancy in 3 tertiary care centers. , 2005, American journal of obstetrics and gynecology.
[429] T. Bogard,et al. The use of nitroglycerin in preventing the hypertensive response to tracheal intubation in severe preeclampsia. , 1986, Anesthesiology.
[430] W. Lombardi,et al. Wellness intervention with pregnant soldiers. , 1999, Military Medicine.
[431] M. Habiba,et al. Patient Initiated Home Blood Pressure Recordings Are Accurate in Hypertensive Pregnant Women , 2003, Hypertension in pregnancy.
[432] J. Cutler,et al. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy , 2003, Hypertension in pregnancy.
[433] J. Davison,et al. Chronic kidney disease in pregnancy , 2008, BMJ : British Medical Journal.
[434] E. Hook,et al. The Association Between Maternal Serum Alpha‐Fetoprotein and Preterm Birth, Small for Gestational Age Infants, Preeclampsia, and Placental Complications , 1996, Obstetrics and gynecology.
[435] B. Sibai,et al. Vitamin C and E supplementation in women at high risk for preeclampsia: a double-blind, placebo-controlled trial. , 2005, American journal of obstetrics and gynecology.
[436] J. Piper,et al. Preeclampsia: Is Induction of Labor More Successful? , 1997, Obstetrics and gynecology.
[437] C. Michael. Intravenous Labetalol and Intravenous Diazoxide in Severe Hypertension Complicating Pregnancy , 1986, The Australian & New Zealand journal of obstetrics & gynaecology.
[438] M. Helewa,et al. Patient satisfaction with an antepartum home-care program. , 1994, Journal of obstetric, gynecologic, and neonatal nursing : JOGNN.
[439] M. López-Llera,et al. Pregnancy after eclampsia. , 1974, American journal of obstetrics and gynecology.
[440] R. Liston,et al. Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women: systematic review , 2008, BMJ : British Medical Journal.
[441] S. Karumanchi,et al. Angiogenic factors and preeclampsia. , 2007, Frontiers in bioscience : a journal and virtual library.
[442] A. Shennan,et al. Rapid Assessment of Blood Pressure in the Obstetric Day Unit Using Microlife MaM Technology , 2007, Hypertension in pregnancy.
[443] S. Cnattingius,et al. Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study , 2006, The Lancet.
[444] John A. Heit,et al. Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition) , 2009, Regional Anesthesia & Pain Medicine.
[445] H. Dinç,et al. Comparison of cerebral magnetic resonance and electroencephalogram findings in pre‐eclamptic and eclamptic women , 2005, The Australian & New Zealand journal of obstetrics & gynaecology.
[446] T. Easterling,et al. Treatment of Hypertension in Pregnancy: Effect of Atenolol on Maternal Disease, Preterm Delivery, and Fetal Growth , 2001, Obstetrics and gynecology.
[447] G. Lip,et al. Atenolol and fetal growth in pregnancies complicated by hypertension. , 1999, American journal of hypertension.
[448] J. Craig,et al. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. , 2005, The Cochrane database of systematic reviews.
[449] B. Sibai,et al. Subsequent pregnancy outcome in women with a history of HELLP syndrome at < or = 28 weeks of gestation. , 2003, American journal of obstetrics and gynecology.
[450] J. Kingdom,et al. Mid-Trimester Placentation Assessment in High-Risk Pregnancies Using Maternal Serum Screening and Uterine Artery Doppler , 2005, Hypertension in pregnancy.
[451] T. Pickering,et al. Principles and techniques of blood pressure measurement. , 2002, Cardiology clinics.
[452] R. Carr-Hill,et al. Pre-eclampsia in second pregnancy. , 1985, British journal of obstetrics and gynaecology.
[453] A. Pastuszak,et al. Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy--United States, Canada, and Israel, 1987-1995. , 1997, MMWR. Morbidity and mortality weekly report.